

Page 51
Notes:
conferenceseries
.com
Volume 8
Epidemiology: Open Access
ISSN: 2161-1165
Epidemiology 2018
September 17-19, 2018
September 17-19, 2018 | Rome, Italy
8
th
International Conference on
Epidemiology & Public Health
2. Agyemang C, Nyaaba G, Beune E, Meeks K, Owusu-Dabo E, Addo J, et al. Variations in hypertension awareness,
treatment, and control among Ghanaian migrants living in Amsterdam, Berlin, London, and nonmigrant Ghanaians
living in rural and urban Ghana - the RODAM study. Journal of hypertension. 2018;36(1):169-77.
3. Agyemang C, Beune E, Meeks K, Addo J, Aikins AD, Bahendeka S, et al. Innovative ways of studying the effect of
migration on obesity and diabetes beyond the common designs: lessons from the RODAM study. Annals of the New
York Academy of Sciences. 2017;1391(1):54-70.
4. Adjei DN, Stronks K, Adu D, Beune E, Meeks K, Smeeth L, et al. Chronic kidney disease burden among African migrants
in three European countries and in urban and rural Ghana: the RODAM cross-sectional study. Nephrology, dialysis,
transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2018.
5. Agyemang C, Beune E, Meeks K, Owusu-Dabo E, Agyei-Baffour P, Aikins A, et al. Rationale and cross-sectional
study design of the Research on Obesity and type 2 Diabetes among African Migrants: the RODAM study. BMJ open.
2014;4(3):e004877.
Biography
Juliet Addo is a Clinical Research Director in Global Health R&D at GlaxoSmithKline (GSK). She joined the GSK non-communicable diseases (NCDs) Open Lab in 2016
and is currently part of the Global Health Catalyst team working in collaboration with academic partners to address major global health problems. She is a physician and
epidemiologist by training, and was a lecturer in epidemiology at the London School of Hygiene and Tropical Medicine (LSHTM) prior to joining GSK. Her research has
focused on cardiovascular diseases and their risk factors including strokes, hypertension and diabetes and the ethnic and socioeconomic differences in these. She is a
member of the Diploma of Tropical Medicine and Hygiene (DTM&H) Board of the Royal College of Physicians and an Honorary Assistant Professor of Epidemiology at
the LSHTM.
Juliet.x.addo@gsk.com